[{"Assets_0_Q2_USD":229811000.0,"CommonStockSharesOutstanding_0_Q2_shares":58209745.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-33161000.0,"NetIncomeLoss_1_Q2_USD":-15150000.0,"NetIncomeLoss_2_Q2_USD":-27099000.0,"StockholdersEquity_0_Q2_USD":71460000.0,"Ticker":"CCXI","CIK":"1340652","name":"CHEMOCENTRYX, INC.","OfficialName":"ChemoCentryx Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1508212562.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190805"}]